No One Should Face Cancer Alone.
Let's Work Together So That No One Will.

NeoGenomics is committed to developing the technical and personal touchpoints to help guide patients and providers to the best solutions and achieve results that matter. From connecting community-based providers to cutting-edge cancer diagnostics to aggregating genomic data to help patients find targeted therapies and clinical trials, NeoGenomics is paving the way forward for every cancer patient today while creating a roadmap to improve outcomes tomorrow.

Our multimodal approach to testing and vast community outreach helps us build a solid network of oncology providers as we unite to serve their patients. Those collaborations fuel our database with insights to inspire our biopharma partners to blaze new trails in research, clinical trial design, and drug development. Working together, we can save lives and the most precious commodity for cancer patients—time.




Precision Insights Driven by Unparalleled Community Data

Real-time signals, deep analytics and insights to drive your brand’s efforts in advancing biomarker testing and awareness of targeted therapies in oncology. We partner with leading brand teams from the top 20 pharma to small biopharma to help them amplify their diagnostic testing and precision medicine strategy.


Next-Generation Cohort Building

NeoAccelerate is a cloud-native research platform designed to make the most of our clinico-genomic database. Using tools such as Cohort Builder, clinical researchers can build cohorts of patient populations in seconds and glean meaningful insights through rich visualizations.

Have data of your own? We can link our data together to power evidence generation activities that advance HEOR and evidence generation across clinical programs.


Image-powered Insights for Discovery, Development and Clinical Operations

Our digital pathology tools and professional services help accelerate diagnostic and drug development. Access our deeply curated pathology image bank, work with our team of Pathologists and AI experts on custom algorithm development and access our AI Sandbox. Bring your digital pathology projects to us, and deploy your asset seamlessly into our network of global labs.


Advanced Clinical Decision Support for Precision Oncology Testing and Treatment

Trapelo® is the only collaborative clinical-decision-support platform that integrates prior authorization into the clinical workflow in real time to give patients the most appropriate, evidence-based options when time matters most.


The Difference Is In Our Data

Succeed sooner with data-powered solutions

cross community capture icon
Cross-Community Capture

We collect diagnostic data from diverse communities located throughout the U.S. and access more than 1.9M patient profiles from more than 68K unique providers and 4,400 organizations.

Multimodal Diagnostic Insights Icon
Multimodal Diagnostic Insights

Beyond NGS testing, we offer various genetic, molecular assays (IHC, FISH, Flow Cytometry, Cytogenetics), capturing multiple cancer diagnoses and prognosis stages. With more than 8,000 samples added daily, our diagnostic insights remain actionable and evolving.

Data Details Icon
Data Details

Our data includes structured EMR entries, free-text interpretations, and whole-slide pathology images. Information on genomic alterations, computational biomarkers, and PD-L1 results are also available.



Unique Patients


Historical Data


Tests Per Year




Unique Providers


Patients Per Year